81
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Generation of stable monoclonal antibody-producing BCR + human memory B cells by genetic programming

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          B cell lymphoma (BCL)6 and Bcl-xL are expressed in germinal center (GC) B cells and enable them to endure the proliferative and mutagenic environment of the GC. By introducing these genes into peripheral blood memory B cells and culturing these cells with factors produced by follicular helper T cells, CD40L and IL-21, we convert them to highly proliferating, cell surface BCR positive, Ig-secreting B cells with features of GC B cells including expression of activation-induced cytidine deaminase. We generated cloned lines of B cells specific for respiratory syncytial virus and used these cells as a source of antibodies that effectively neutralized this virus in vivo. This method provides a new tool to study GC B cell biology, signal transduction through antigen-specific B cell receptors, and for the rapid generation of high affinity human monoclonal antibodies.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.

          Induced overexpression of AID in CH12F3-2 B lymphoma cells augmented class switching from IgM to IgA without cytokine stimulation. AID deficiency caused a complete defect in class switching and showed a hyper-IgM phenotype with enlarged germinal centers containing strongly activated B cells before or after immunization. AID-/- spleen cells stimulated in vitro with LPS and cytokines failed to undergo class switch recombination although they expressed germline transcripts. Immunization of AID-/- chimera with 4-hydroxy-3-nitrophenylacetyl (NP) chicken gamma-globulin induced neither accumulation of mutations in the NP-specific variable region gene nor class switching. These results suggest that AID may be involved in regulation or catalysis of the DNA modification step of both class switching and somatic hypermutation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells.

            Blimp-1 is a transcriptional repressor able to drive the terminal differentiation of B cells into Ig-secreting plasma cells. We have created mice with a B cell-specific deletion of prdm1, the gene encoding Blimp-1. B cell development and the number of B cells responding to antigen appear to be normal in these mice. However, in response to either TD or TI antigen, serum Ig, short-lived plasma cells, post-GC plasma cells, and plasma cells in a memory response are virtually absent, demonstrating that Blimp-1 is required for plasmacytic differentiation and Ig secretion. In the absence of Blimp-1, CD79b(+)B220(-) pre-plasma memory B cell development is also defective, providing evidence that this subset is an intermediate in plasma cell development. B cells lacking Blimp-1 cannot secrete Ig or induce muS mRNA when stimulated ex vivo. Furthermore, although prdm1-/- B cells fail to induce XBP-1, XBP-1 cannot rescue plasmacytic differentiation without Blimp-1.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Regulation of plasma-cell development.

              Plasma cells are the terminally differentiated, non-dividing effector cells of the B-cell lineage. They are cellular factories devoted to the task of synthesizing and secreting thousands of molecules of clonospecific antibody each second. To respond to microbial pathogens with the necessary specificity and rapidity, B cells are exquisitely regulated with respect to both development in the bone marrow and activation in the periphery. This review focuses on the terminal differentiation of B cells into plasma cells, including the different subsets of B cells that become plasma cells, the mechanism of regulation of this transition, the transcription factors that control each developmental stage and the characteristics of long-lived plasma cells.
                Bookmark

                Author and article information

                Journal
                9502015
                8791
                Nat Med
                Nat. Med.
                Nature medicine
                1078-8956
                1546-170X
                18 February 2010
                20 December 2009
                January 2010
                01 July 2010
                : 16
                : 1
                : 123-128
                Affiliations
                [1 ]AIMM Therapeutics, Academic Medical Center, Amsterdam, The Netherlands
                [2 ]Department of Cell Biology and Histology, Academic Medical Center, Amsterdam, The Netherlands
                [4 ]Department of Pediatrics, The Wilhelmina Children's Hospital, University Medical Center, Utrecht
                [5 ]Netherlands Vaccine Institute, Bilthoven
                [6 ]Department of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands
                [7 ]German Rheumatism Research Center, Berlin, Germany
                Author notes
                Correspondence: Tim Beaumont: tbeaumont@ 123456aimmtherapeutics.com
                [3]

                Current address: Department of Medicine, University of Vermont, Burlington, VT, USA

                [8]

                Current address: Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, CA, USA

                [9]

                Current address: Department of Immunology, Genentech, South San Francisco, CA, USA.

                [*]

                These authors contributed equally to this work.

                Article
                NIHMS178733
                10.1038/nm.2071
                2861345
                20023635
                1fac87e0-d0cd-423d-aa14-dc0595ba1b7a
                History
                Funding
                Funded by: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
                Award ID: F32 AI063846-03X1 || AI
                Funded by: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
                Award ID: F32 AI063846-03 || AI
                Funded by: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
                Award ID: F32 AI063846-02X1 || AI
                Funded by: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
                Award ID: F32 AI063846-02 || AI
                Funded by: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
                Award ID: F32 AI063846-01A1X1 || AI
                Funded by: National Institute of Allergy and Infectious Diseases Extramural Activities : NIAID
                Award ID: F32 AI063846-01A1 || AI
                Categories
                Article

                Medicine
                Medicine

                Comments

                Comment on this article